9 completed, 3 unknown, 1 recruiting. 4 Not applicable, 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Oligomenorrhea: new trials by email Literature Review of Oligomenorrhea trials Research Report on Oligomenorrhea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| This Study Aims to Evaluate Whether Milamend's Product Could Improve Hormone Balance in Women Who Suffer From Self-reported PCOS Symptoms. A dietary supplement powder for women, Placebo - Polycystic Ovarian Syndrome (PCOS) | Not applicable | Recruiting | Mila Mend Inc. | 225 | 2025-12-23 | 2026-08-13 |
| Myo-Inositol and D-Chiro-Inositol for Menstrual Irregularities and Hormone Changes in Women With Polycystic Ovarian Syndrome Myo-Inositol and D-Chiro-Inositol Combination Therapy, placebo (folic acid) - Polycystic Ovary Syndrome (PCOS), Myo-inositol | Phase 4 | Completed | Nishtar Medical University | 60 | 2025-06-01 | 2026-07-14 |
| Treatment of Menstrual Cycle Alterations in Adolescents myo-Inositol plus DIoscorea Villosa - Amenorrhea, Oligomenorrhea | Not applicable | Completed | Lo.Li.Pharma s.r.l | 41 | 2025-06-01 | 2026-10-09 |
| Phenotype and Epidemiology of the Polycystic Ovary Syndrome (PCOS) in Colombia (PEP - Colombia) Study. Diagnostic Ultrasound, Venous puncture - Polycystic Ovary Syndrome, Hyperandrogenism | Unknown | Instituto de fertilidad humana, InSer | 626 | 2023-03-04 | 2023-07-03 | |
| Acupuncture for Oligomenorrhea Due to Polycystic Ovary Syndrome Acupuncture+Usual care, Usual care - Polycystic Ovary Syndrome, Oligomenorrhea | Not applicable | Unknown | China Academy of Chinese Medical Sciences | 60 | 2020-11-01 | 2020-10-29 |
| Prevalence of Hyperandrogenism in Type 1 Diabetes Clinical hyperandrogenism assessment, Total testosterone (ng/dL), A1c (%) - Type 1 Diabetes, Polycystic Ovary Syndrome | Completed | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 150 | 2020-03-09 | 2025-03-17 | |
| Ovarian Morphology in Girls Amenorrhea, Oligomenorrhea | Unknown | Cornell University | 60 | 2020-01-31 | 2024-08-12 | |
| Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women Flutamide, Placebo - Polycystic Ovary Syndrome (PCOS) | Phase 2 | Completed | University of California, Los Angeles | 23 | 2013-04-01 | 2025-01-10 |
| Ultrasound Characterization of Ovarian Follicle Dynamics in Women With Amenorrhea Oligomenorrhea, Amenorrhea | Completed | Cornell University | 73 | 2011-09-01 | 2024-02-09 | |
| Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS) Dexamethasone, recombinant human chorionic gonadotropin (r-hCG) - PCOS | Phase 3 | Completed | University of California, San Diego | 24 | 2011-08-01 | 2019-04-30 |
| Adrenal Hyperplasia Among Young People With PCOS Adrenal Hyperplasia, Polycystic Ovarian Syndrome | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 96 | 2011-03-10 | 2019-05-31 | |
| Bioenergetics of Exercise-Induced Menstrual Disturbances Sedentary Control, Exercising control, 15 percent energy deficit - Menstruation Disturbances, Luteal Phase Defect | Not applicable | Completed | Penn State University | 47 | 2001-05-01 | 2021-06-24 |
| Reproductive Effects of Pesticide, PCB and Mercury Exposure in Laotian Immigrants Amenorrhea, Dysmenorrhea | Completed | National Institute of Environmental Health Sciences (NIEHS) | 50 | 2006-03-23 |
Polycystic Ovary Syndrome (9) · Amenorrhea (7) · Hyperandrogenism (6) · Menstruation Disturbances (4) · Anovulation (3) · Hirsutism (3) · Adrenal Hyperplasia, Congenital (1) · Diabetes Mellitus, Type 1 (1) · Dysmenorrhea (1) · Endocrine System Diseases (1) · Infertility (1) · Insulin Resistance (1) · Menorrhagia (1) · Obesity (1)
Pathologic Processes (13) · Pathological Conditions, Signs and Symptoms (13) · Adnexal Diseases (10) · Female Urogenital Diseases (10) · Female Urogenital Diseases and Pregnancy Complications (10) · Genital Diseases (10) · Genital Diseases, Female (10) · Gonadal Disorders (10) · Ovarian Diseases (10) · Urogenital Diseases (10) · Cysts (9) · Endocrine System Diseases (9) · Menstruation Disturbances (9) · Neoplasms (9) · Ovarian Cysts (9)
Inositol (2) · Body Composition (1) · Body Mass Index (1) · Cardiovascular Physiological Phenomena (1) · Chorionic Gonadotropin (1) · Dexamethasone (1) · Diet (1) · Exercise (1) · Flutamide (1) · Folic Acid (1) · Hematologic Tests (1) · Insulin (1) · Ovidrel (1) · Time (1) · Ultrasonography (1)
Cornell University (2) · China Academy of Chinese Medical Sciences (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal (1) · Instituto de fertilidad humana, InSer (1) · Lo.Li.Pharma s.r.l (1) · Mila Mend Inc. (1) · National Institute of Environmental Health Sciences (NIEHS) (1) · Nishtar Medical University (1) · Penn State University (1) · University of California, Los Angeles (1) · University of California, San Diego (1)
United States (6) · China (1) · Colombia (1) · Georgia (1) · Pakistan (1) · Russia (1) · South Korea (1) · Spain (1)
Chunlan Jin, MD (1) · Daniel Dumesic, MD (1) · Kathleen Hoeger, MD (1) · Marla E Lujan, PhD (1) · Marla E. Lujan, PhD (1) · Maya B Lodish, M.D. (1) · Mehnaz K Professor, FCPS (1) · Nancy I Williams, ScD (1) · R. Jeffery Chang, M.D. (1) · Ricardo Azziz, M.D. (1) · Romina Barral, MD MSCR FAPP (1) · Tania Burgert, MD (1)
PMID 25352438, PMID 27336356, PMID 29023359, PMID 35363161, PMID 36400597, PMID 36708012, PMID 38335228, PMID 41868592
R01HD039245 (1)